ERIN CURRAN: Open Payments
NPI 1942891395 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,743 in 133 payments from 27 companies in 2025. Trend: 2023 $1,579 · 2024 $3,538 · 2025 $2,743
Food & beverage: $2,559Education: $184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $493 |
| Galderma Laboratories, L.P. | 8 | $261 |
| Novartis Pharmaceuticals Corporation | 23 | $257 |
| UCB, Inc. | 14 | $232 |
| Janssen Biotech, Inc. | 6 | $183 |
| PFIZER INC. | 3 | $154 |
| LEO Pharma Inc. | 9 | $148 |
| Organon LLC | 10 | $117 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $102 |
| GENZYME CORPORATION | 3 | $97 |
Products named: SKYRIZI, COSENTYX, NEMLUVIO, DUPIXENT, Bimzelx, TREMFYA, RINVOQ, CIBINQO.
Industry payments across MS — which companies pay providers there.
